Form 4: Medtronic EVP Karen Parkhill Reports Stock Transactions

Karen Parkhill, EVP & Chief Financial Officer of Medtronic, reports the settlement of performance share units and related tax withholdings.

Summary

• Karen Parkhill, EVP & Chief Financial Officer of Medtronic, filed a Form 4 detailing changes in beneficial ownership of Medtronic plc [MDT] stock.
• On August 2, 2024, Parkhill settled 7,132 performance share units, receiving shares and dividend equivalents.
• Shares were withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.
• Shares were also withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
• Following these transactions, Parkhill directly owns 46,730 ordinary shares and indirectly owns 49,859 ordinary shares through the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which she is the trustee and a beneficiary.
• She also indirectly owns 843 shares each through Child #1, Child #2 and Child #3.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, and carries a neutral sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Comparison to Industry Standards

• Executive compensation packages including performance share units are standard practice among large, publicly traded companies like Medtronic.
• Tax withholding upon vesting of restricted stock units is a common occurrence.
• Similar filings are regularly made by executives at comparable companies such as Johnson & Johnson, Abbott Laboratories, and Boston Scientific.

Key Dates